Cargando…
Amantadine: reappraisal of the timeless diamond—target updates and novel therapeutic potentials
The aim of the current review was to provide a new, in-depth insight into possible pharmacological targets of amantadine to pave the way to extending its therapeutic use to further indications beyond Parkinson’s disease symptoms and viral infections. Considering amantadine’s affinities in vitro and...
Autores principales: | Danysz, Wojciech, Dekundy, Andrzej, Scheschonka, Astrid, Riederer, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901515/ https://www.ncbi.nlm.nih.gov/pubmed/33624170 http://dx.doi.org/10.1007/s00702-021-02306-2 |
Ejemplares similares
-
Selegiline: a molecule with innovative potential
por: Tábi, Tamás, et al.
Publicado: (2019) -
L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
por: Riederer, Peter, et al.
Publicado: (2023) -
The Effect of Amantadine on Agitation in the Pediatric Traumatic Brain Injury Population: A Case Series
por: Hon, Emily, et al.
Publicado: (2023) -
Coronaviruses: a challenge of today and a call for extended human postmortem brain analyses
por: Riederer, Peter, et al.
Publicado: (2020) -
Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease
por: Fan, Qian-Ya, et al.
Publicado: (2022)